Follow
xufeng chen
xufeng chen
Verified email at nyumc.org
Title
Cited by
Cited by
Year
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
CD DiNardo, IS Tiong, A Quaglieri, S MacRaild, S Loghavi, FC Brown, ...
Blood, The Journal of the American Society of Hematology 135 (11), 791-803, 2020
4692020
Targeting an RNA-binding protein network in acute myeloid leukemia
E Wang, SX Lu, A Pastore, X Chen, J Imig, SCW Lee, K Hockemeyer, ...
Cancer cell 35 (3), 369-384. e7, 2019
2482019
Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment
X Chen, C Glytsou, H Zhou, S Narang, DE Reyna, A Lopez, ...
Cancer discovery 9 (7), 890-909, 2019
2072019
Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia
A Kloetgen, P Thandapani, P Ntziachristos, Y Ghebrechristos, S Nomikou, ...
Nature genetics 52 (4), 388-400, 2020
1402020
SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2
Q Lu, J Liu, S Zhao, MFG Castro, M Laurent-Rolle, J Dong, X Ran, ...
Immunity 54 (6), 1304-1319. e9, 2021
1332021
Uhrf1 controls the self-renewal versus differentiation of hematopoietic stem cells by epigenetically regulating the cell-division modes
J Zhao, X Chen, G Song, J Zhang, H Liu, X Liu
Proceedings of the National Academy of Sciences 114 (2), E142-E151, 2017
572017
Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation
E Wang, H Zhou, B Nadorp, G Cayanan, X Chen, AH Yeaton, S Nomikou, ...
Cell Stem Cell 28 (4), 718-731. e6, 2021
462021
Uhrf1 controls iNKT cell survival and differentiation through the Akt-mTOR axis
Y Cui, X Chen, J Zhang, X Sun, H Liu, L Bai, C Xu, X Liu
Cell Reports 15 (2), 256-263, 2016
362016
A membrane-associated MHC-I inhibitory axis for cancer immune evasion
X Chen, Q Lu, H Zhou, J Liu, B Nadorp, A Lasry, Z Sun, B Lai, G Rona, ...
Cell 186 (18), 3903-3920. e21, 2023
232023
Interferon regulatory factor 4 regulates thymocyte differentiation by repressing Runx3 expression
Y Cao, H Li, Y Sun, X Chen, H Liu, X Gao, X Liu
European journal of immunology 40 (11), 3198-3209, 2010
232010
Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion
E Battistello, KA Hixon, DE Comstock, CK Collings, X Chen, JR Hernaez, ...
Molecular cell 83 (8), 1216-1236. e12, 2023
152023
The mediator subunit Med23 contributes to controlling T-cell activation and prevents autoimmunity
Y Sun, X Zhu, X Chen, H Liu, Y Xu, Y Chu, G Wang, X Liu
Nature Communications 5 (1), 5225, 2014
132014
Lis1 is required for the expansion of hematopoietic stem cells in the fetal liver
X Chen, J Zhang, J Zhao, H Liu, X Sun, M Zhao, X Liu
Cell research 24 (8), 1013-1016, 2014
112014
Lis1 regulates germinal center B cell antigen acquisition and affinity maturation
J Chen, Z Cai, L Zhang, Y Yin, X Chen, C Chen, Y Zhang, S Zhai, X Long, ...
The Journal of Immunology 198 (11), 4304-4311, 2017
82017
Dynamic 3D chromosomal landscapes in acute leukemia
A Kloetgen, P Thandapani, P Ntziachristos, Y Ghebrechristos, S Nomikou, ...
bioRxiv, 724427, 2019
72019
Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia
C Glytsou, X Chen, E Zacharioudakis, W Al-Santli, H Zhou, B Nadorp, ...
Cancer discovery 13 (7), 1656-1677, 2023
62023
Med23 serves as a gatekeeper of the myeloid potential of hematopoietic stem cells
X Chen, J Zhao, C Gu, Y Cui, Y Dai, G Song, H Liu, H Shen, Y Liu, ...
Nature Communications 9 (1), 3746, 2018
62018
Targeting MHC-I inhibitory pathways for cancer immunotherapy
J Wang, Q Lu, X Chen, I Aifantis
Trends in Immunology, 2024
2024
The effect of chromatin states on cancer: big data lead the way
X Chen, I Aifantis
The Lancet Haematology 5 (6), e237-e238, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–19